Covestor’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152K Buy
1,825
+100
+6% +$8.22K 0.1% 180
2026
Q2
$115K Buy
1,725
+1,199
+228% +$101K 0.07% 290
2026
Q1
$52K Buy
526
+420
+396% +$54.8K 0.04% 698
2025
Q4
$13K Hold
106
– – 0.01% 1463
2025
Q3
$12K Sell
106
-68
-39% -$7.96K 0.01% 1512
2025
Q2
$23K Sell
174
-2
-1% -$220 0.01% 1208
2025
Q1
$12K Buy
176
+102
+138% +$7.02K 0.01% 1413
2024
Q4
$5K Hold
74
– – ﹤0.01% 1733
2024
Q3
$12K Buy
74
+72
+3,600% +$11.1K 0.01% 1461
2024
Q2
$0 Hold
2
– – ﹤0.01% 2758
2024
Q1
$0 Hold
2
– – ﹤0.01% 2739
2023
Q4
$0 Buy
2
+1
+100% +$60 ﹤0.01% 2714
2023
Q3
$0 Sell
1
-2
-67% -$144 ﹤0.01% 2712
2023
Q2
$0 Hold
3
– – ﹤0.01% 2652
2023
Q1
$0 Hold
3
– – ﹤0.01% 2589
2022
Q4
$0 Buy
+3
New +$159 ﹤0.01% 2612

Other funds holding TMDX

Covestor's TMDX Position: Q3 2026 in Review

Covestor increased its Transmedics (TMDX) stake by 5.8% in Q3 2026, buying an estimated $8.22K and bringing the position to 1,825 shares worth $152K. The position accounts for 0.1% of the portfolio, ranked #180.

Covestor first reported a position in TMDX in Q4 2022 and has held it in 16 quarters since. 385 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Covestor held 1,825 shares of Transmedics worth $152K as of Q3 2026.
  • Covestor bought 100 Transmedics shares in Q3 2026, an estimated $8.22K.
  • Transmedics made up 0.1% of Covestor's portfolio in Q3 2026, its #180 holding.
  • Covestor first reported a position in Transmedics in Q4 2022 and has held it in 16 quarters since.
  • 385 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.